Noventure will be attending CPHI Milan 2026 from October 6 to 8.
Published
Signal category
Presence & Recognition
Quote
“Noventure will be at CPHI Milan 2026, from October 6–8.”
— Noventure team
Company
Noventure
Making healthcare better with clinically proven brands that deliver real relief
- Industry
- Pharmaceutical Manufacturing
- Location
- Barcelona, ES
- Company size
- 20 employees
Noventure is a portfolio of clinically proven, consumer-facing healthcare brands trusted by healthcare professionals and patients in more than 50 countries. Our mission is to build trust for people all around the world by providing clinically-backed products that offer real relief without harm—so they can live healthier, freer lives without fear or doubt in their care. Our brands, including Tasectan, Utipro Plus, and Ulkox, are: • Backed by clinical trials • Included in treatment guidelines • CE-marked and MDR Class III compliant • Protected by patents We work with leading pharmaceutical partners worldwide to make our products the number one choice in their therapeutic class.
Founded 2000